Oncology - InSphero


Accelerating cancer drug development

November 27, 2020
Season's Greetings

2020 Year In Review: Rising to New Challenges

InSphero CEO Jan Lichtenberg extends holiday greetings from our teams in Switzerland and the United States and looks back on the highlights of 2020: a tumultuous year shaped by a […]
May 1, 2020
Live-cell imaging of immune cell infiltration in a 3D lung carcinoma model:

The Future of High Content Analysis is 3D

InSphero recently had an opportunity to test the Yokogawa Platform for 3D High Content Analysis (HCA) in our laboratories in Schlieren, Switzerland. Our goal was to see whether the Yokogawa […]
March 13, 2020
InSphero Live Webinar

InSphero Launches New Webinar Series!

As the coronavirus pandemic prompts cancellations of scientific meetings around the world and shifts to virtual settings, we have been working on alternative methods to keep you informed of advances […]
February 26, 2020
CAR-T Attack

Do Immuno-Oncology therapeutics make traditional in vitro assays obsolete?

InSphero Oncology Experts Francesca Chiovaro and Irina Agarkova often collaborate closely with academic and pharma partners who are developing therapeutics that target the innate immune system. In this blog, Francesca shares […]
December 18, 2019
Scalable Akura Plate Technology

InSphero marks 10 years of innovation in 3D cell-based technology

InSphero CEO Jan Lichtenberg muses about how far 3D cell-based technology has come since InSphero was founded in 2009 and shares the latest news about how our disruptive 3D technology […]